Latest Continuous Disclosure News

Rubicon Water has told ASX that the selection of a joint venture bid containing about A$12 million of its technology was price-sensitive information. The company said it only learned of the decision when it appeared on Morocco’s procurement portal, then lodged its announcement after an overnight review and a four-second technical delay.

Suncorp Group has rejected speculation that it is in takeover discussions with Tokio Marine after its shares climbed from $19.05 to $20.18 and trading volumes increased. The insurer told the ASX it had received no takeover offer and knew of no undisclosed information explaining the move.

Cauldron Energy has told the ASX it knows of no undisclosed information behind a sharp fall in its share price and a surge in trading activity. The company has pointed instead to a possible Betashares Global Uranium ETF rebalance, while stressing that explanation remains unconfirmed.

Metrics Income Opportunities Trust has been suspended from trading after its responsible entity warned that the audited FY2026 financial report may differ materially from figures released in August. The final report is expected on 30 September, but the filing does not disclose the size or direction of the changes.

Metrics Real Estate Multi-Strategy Fund units have been suspended at the fund’s request after its responsible entity warned that the final audited 2026 financial report may differ materially from figures released in August. The report is expected on 30 September.

Metrics Master Income Trust has been suspended from trading after warning that its audited FY2026 financial report may differ materially from unaudited figures released last month. The final report is expected on 30 September, but the trust has not disclosed the nature or size of the revisions.

BOA Resources says it is unaware of undisclosed information behind a sharp increase in trading, despite further Ricci Lee assay results remaining pending through October. The company attributed the move to investor reaction to its recent high-grade copper announcement.

Vection Technologies has signed reciprocal five-year reseller agreements with Xerox, opening a potential Western European channel for its conversational AI, digital human, kiosk and XR technologies. The opportunity is strategically notable, but the agreements contain no minimum volumes, pricing or committed revenue.

OFX says it remains in active discussions with Equals over a proposed all-cash acquisition after ASX questioned a sharp fall in its share price and a surge in trading volume. The parties are negotiating a possible extension to exclusivity, but no agreement has been reached.

Micro-X has told ASX it is unaware of any undisclosed information explaining the sharp move in its shares, which rose from $0.030 to $0.045 during 23 September trading. The company pointed to elevated volumes, earlier institutional selling and chairman Patrick O’Brien’s purchase of 1.36 million shares.

Paradigm Biopharmaceuticals has secured a voluntary suspension of its ASX securities while it prepares to release interim analysis results from its PARA_OA_012 Phase 3 trial. The announcement gives no indication whether the clinical readout is favourable or unfavourable, with trading potentially resuming on 28 September subject to ASX approval.

Bridge SaaS has told ASX it knows of no undisclosed information behind a sharp share price fall and significant increase in trading volume. The response confirms compliance with continuous disclosure rules but leaves the market activity unexplained.